SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-028969
Filing Date
2018-11-09
Accepted
2018-11-09 17:14:10
Documents
68
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q flgt-10q_20180930.htm 10-Q 2087887
2 EX-31.1 flgt-ex311_8.htm EX-31.1 19180
3 EX-31.2 flgt-ex312_7.htm EX-31.2 18847
4 EX-32.1 flgt-ex321_6.htm EX-32.1 18028
  Complete submission text file 0001564590-18-028969.txt   7630600

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT flgt-20180930.xml EX-101.INS 1950154
6 XBRL TAXONOMY EXTENSION SCHEMA flgt-20180930.xsd EX-101.SCH 43904
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE flgt-20180930_cal.xml EX-101.CAL 40021
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE flgt-20180930_def.xml EX-101.DEF 132420
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE flgt-20180930_lab.xml EX-101.LAB 314058
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE flgt-20180930_pre.xml EX-101.PRE 254421
Mailing Address 4978 SANTA ANITA AVENUE, SUITE 205 TEMPLE CITY CA 91780
Business Address 4978 SANTA ANITA AVENUE, SUITE 205 TEMPLE CITY CA 91780 626-350-0537
Fulgent Genetics, Inc. (Filer) CIK: 0001674930 (see all company filings)

IRS No.: 812621304 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37894 | Film No.: 181174005
SIC: 8071 Services-Medical Laboratories
Assistant Director 9